983 related articles for article (PubMed ID: 19605522)
21. Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation.
Sharif NA; Drace CD; Williams GW; Crider JY
J Pharm Pharmacol; 2004 Oct; 56(10):1267-74. PubMed ID: 15482641
[TBL] [Abstract][Full Text] [Related]
22. Phrenic nerve activity is enhanced by 5-HT1A receptor agonist 8-OH-DPAT in spontaneously breathing anesthetized rats.
Valic M; Pecotic R; Dogas Z
J Physiol Pharmacol; 2008 Mar; 59(1):17-25. PubMed ID: 18441384
[TBL] [Abstract][Full Text] [Related]
23. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
24. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
[TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
26. Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.
Heusler P; Rauly-Lestienne I; Tourette A; Tardif S; Ailhaud MC; Croville G; Cussac D
Eur J Pharmacol; 2010 Aug; 640(1-3):8-14. PubMed ID: 20450907
[TBL] [Abstract][Full Text] [Related]
27. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
[TBL] [Abstract][Full Text] [Related]
28. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC
J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450
[TBL] [Abstract][Full Text] [Related]
29. Competitive interaction of 5-HT(1A) receptors with G-protein subtypes in CHO cells demonstrated by RNA interference.
Rauly-Lestienne I; Lestienne F; Ailhaud MC; Binesse J; Newman-Tancredi A; Cussac D
Cell Signal; 2011 Jan; 23(1):58-64. PubMed ID: 20727408
[TBL] [Abstract][Full Text] [Related]
30. Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-kappaB-dependent cell survival after serotonin 1A receptor activation.
Hsiung SC; Tamir H; Franke TF; Liu KP
J Neurochem; 2005 Dec; 95(6):1653-66. PubMed ID: 16238696
[TBL] [Abstract][Full Text] [Related]
31. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
Bardin L; Colpaert FC
Eur J Pain; 2004 Jun; 8(3):253-61. PubMed ID: 15109976
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological studies of 8-OH-DPAT-induced pupillary dilation in anesthetized rats.
Yu Y; Ramage AG; Koss MC
Eur J Pharmacol; 2004 Apr; 489(3):207-13. PubMed ID: 15087245
[TBL] [Abstract][Full Text] [Related]
33. Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.
Bert B; Fink H; Hörtnagl H; Veh RW; Davies B; Theuring F; Kusserow H
Behav Brain Res; 2006 Feb; 167(2):328-41. PubMed ID: 16256213
[TBL] [Abstract][Full Text] [Related]
34. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
[TBL] [Abstract][Full Text] [Related]
35. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
37. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
38. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
Iravani MM; Tayarani-Binazir K; Chu WB; Jackson MJ; Jenner P
J Pharmacol Exp Ther; 2006 Dec; 319(3):1225-34. PubMed ID: 16959959
[TBL] [Abstract][Full Text] [Related]
39. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
